Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
about
Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.Capnocytophaga in the dental plaque of immunocompromised children with cancer.B-Cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer.In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation.Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective studyInhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.Recovery of uncommon bacteria from blood: association with neoplastic diseaseIn vitro susceptibility of Capnocytophaga species to antimicrobial agents.Mixed bacteremia with Capnocytophaga sputigena and Escherichia coli following bone marrow transplantation: case report and review.Brain abscess associated with multidrug-resistant Capnocytophaga ochracea infection.Capnocytophaga bacteraemia following rituximab treatment.Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.Intra-amniotic infection caused by capnocytophaga species.Use of adhesin-specific monoclonal antibodies to identify and localize an adhesin on the surface of Capnocytophaga gingivalis DR2001Sensitivity of Capnocytophaga species to bactericidal properties of human serum.Capnocytophaga spp. DF-1 pneumonia in an immune-competent 56-year old man post-CABG.Bacteremia by multidrug-resistant Capnocytophaga sputigenaInguinal lymphadenitis associated with Capnocytophaga bacilliNovel beta-lactamase from Capnocytophaga sp.In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.Peritonitis involving a Capnocytophaga sp. in a patient undergoing continuous ambulatory peritoneal dialysis.Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.Serological cross-reaction between Legionella spp. and Capnocytophaga ochracea by using latex agglutination test.Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.Capnocytophaga lung abscess in a patient with metastatic neuroendocrine tumor.Capnocytophagal pneumonia in a healthy man.Eight cases of Capnocytophaga infections in Denmark.Etiologic diagnosis of Capnocytophaga canimorsus meningitis by broad-range PCR.Knowing where to look: 'Meningococcal' septicaemia following a dog bite
P2860
Q24805126-BF12C51E-4502-433D-BA2E-7859799A55EAQ33232317-351C56ED-0BD7-433F-BA71-67059C755F7AQ33591666-4F77B44B-DC72-426A-861D-6FA89B91AE65Q33595043-B00C1E37-E330-43BD-97D9-5E9F30961930Q34110452-92070FBD-877A-49D6-BFC4-B9AD5034CDDCQ34799946-10AFEE77-9B30-46A2-96C1-CD1D0BD4E69AQ35230082-ABDED516-408A-46DF-981E-26AE320DE595Q35535042-08130743-CC49-4773-8430-58193F682632Q35537106-4DC1680C-7B19-4829-A14A-05078FDB9B74Q35623947-D86CFCED-C902-4FF2-86CA-6616B3BAF5EAQ35690514-6B3D0A7C-C77A-4395-9C4C-A855FABD0910Q35976120-3BEB5261-0984-4DB2-B8D3-55139A8E2C73Q36240781-0902BA42-CF37-48E6-A84E-45549FEC6168Q36625173-6B166D29-0C74-4C36-90E1-92E5094AD459Q37005558-84BED7B0-3702-4498-ADA5-019CAB18E02DQ37052911-CAB737B1-32A6-4D44-9192-18C1BADA8945Q37111235-2250208A-C0A1-4ED8-AC3C-C5016D9363C4Q37165811-B96FCFDD-BAAE-4AC2-A6F5-034A4368A40BQ37233569-DFB4BCCA-62E7-4ABF-842C-317F5F5F71A5Q39816556-BF72185B-F28A-4AFF-B04E-DFEDE2C7D7C5Q39828606-050629E3-E3E3-4034-82E4-2499A7B63022Q39883789-015A046D-D8D7-4FA0-BBA2-DF8CCDCEA653Q40008778-3140F67E-968F-4F39-AEFA-2933E727BE87Q40088551-F1BF5362-07C0-4CE4-9D5B-9152093CF726Q40181296-E99D0FC8-E902-417A-8AA6-D9B64AFEE09AQ40337687-0C121F4B-89B3-4AAC-9B71-3E86799E7C36Q40348542-834273FA-929F-46B0-9ADF-8BC2A466C7A5Q42574351-F779AB54-21BC-45EB-BB35-562FC802B3F3Q44649233-5A8B8E6A-2A0B-4A7E-9B21-D30CFCEC9218Q46947797-C7140D38-4987-48CA-8BA5-33F3EF578626Q57210718-4204C9DE-618D-464E-BBF1-7A7D3E36FAB3
P2860
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@en
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@nl
type
label
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@en
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@nl
prefLabel
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@en
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@nl
P356
P1476
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.
@en
P2093
Parenti DM
Snydman DR
P304
P356
10.1093/INFDIS/151.1.140
P407
P577
1985-01-01T00:00:00Z